HMGB1 and metabolic dysfunction-associated steatohepatitis: Ablation of HMGB1 leads to lipid accumulation in jejunal IEC, decreases chylomicron packaging and/or release, reduces serum triglycerides (TG) and mitigates liver steatosis, thus preventing HMGB1 ΔIEC mice from high‐fat, high‐cholesterol and fructose‐enriched diet (HFCFD) induced‐NASH.49